EDITAS MEDICINE INC. - COMMON STOCK

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

07 Apr 2025 09:45:16 By NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

04 Apr 2025 09:45:24 By NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

03 Apr 2025 16:14:13 By NetDania Notify

Editas Medicine Announces Chief Financial Officer Transition

20 Mar 2025 16:01:00 By Nasdaq GlobeNewswire

Editas Medicine Announces Fourth Quarter and Full Year 2024 Results and Business Updates

05 Mar 2025 16:05:00 By Nasdaq GlobeNewswire

Editas Medicine to Announce Fourth Quarter/Full Year 2024 Financial Results and to Participate in Investor Conferences in March

24 Feb 2025 09:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

14 Jan 2025 09:52:51 By NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

13 Jan 2025 15:37:06 By NetDania Notify

Editas Medicine Highlights New In Vivo Preclinical Proof of Concept Data, Anticipated 2025 Key Milestones, and Three-year Strategic Priorities

13 Jan 2025 09:00:00 By Nasdaq GlobeNewswire

Editas Medicine to Present at the 43rd Annual J.P. Morgan Healthcare Conference

06 Jan 2025 09:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

26 Dec 2024 09:45:04 By NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

24 Dec 2024 09:49:19 By NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

23 Dec 2024 10:33:49 By NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

19 Dec 2024 09:58:23 By NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

18 Dec 2024 15:10:06 By NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

16 Dec 2024 09:45:55 By NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

13 Dec 2024 09:45:12 By NetDania Notify

Editas Medicine Announces Strategic Transition to in vivo Gene Editing Company with Intent to Achieve Human Proof of Concept in Approximately Two Years

12 Dec 2024 16:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

12 Dec 2024 12:03:55 By NetDania Notify

Editas Medicine Reports Updated Clinical Data from the RUBY Trial of Reni-cel in Patients with Severe Sickle Cell Disease at the American Society of Hematology (ASH) Annual Meeting

09 Dec 2024 12:00:00 By Nasdaq GlobeNewswire